Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1COHANCE LIFESCIENCES LIMITED Mumbai IN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

CEP 2015-150 - Rev 01
Valid
Chemical
2024-07-09
2640
Cohance

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Certificate Number : CEP 2015-150 - Rev 01

Status : Valid

Issue Date : 2024-07-09

Type : Chemical

Substance Number : 2640

Cohance

Looking for Certificates of Suitability (CEPs) for CEP 2015-150 - Rev 01 of Cohance Lifesciences Limited Mumbai In

Looking for Certificates of Suitability (CEPs) for CEP 2015-150 - Rev 01 of Cohance Lifesciences Limited Mumbai In 1

20

Cohance Lifesciences Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

One of their significant offerings is Atomoxetine hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2015-150 - Rev 01

This Chemical Type CEP, issued on July 09, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2640 associated with this CEP further emphasizes